Ethamsylate clinical trials
Also written Etamsylate.
How each study uses Ethamsylate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Ethamsylate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Other names
- Etamsylate
- 2
Studies by the year they started
4 studies that test it; most in 2015 (1)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2020 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 3
Egymedicalpedia (1) · University of Sfax (1) · First Affiliated Hospital of Zhejiang University (1) · Ahmed Alanwar (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test Ethamsylate, phase 3 first.
- Oct 2027Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCTPhase 3 · First Affiliated Hospital of Zhejiang University
Studies
Open first, then newest update. How each study uses Ethamsylate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCTRecruitingPhase 3First Affiliated Hospital of Zhejiang UniversityNCT07442513Written as etamsylateHow we know
- Can Administration of Etamsylate Reduce Postpancreatectomy HemorrhageNot yet recruitingNot applicableUniversity of SfaxNCT06190535Written as EtamsylateHow we know
- Comparative Study Between Oxytocin Versus Tranexamic Acid and EthamsylateCompletedPhase 1/2EgymedicalpediaNCT04656067Written as Oxytocin ,Tranexamic acid and EthamsylateHow we know
- Tranexamic Acid and Ethamsylate For Preventing PPH in Patient Undergoing LSCS at High Risk For PPHStatus unknownPhase 1/2Ahmed AlanwarNCT02604719Written as Tranexamic Acid and EthamsylateHow we know
Codes
What other systems call Ethamsylate · ClinicalTrials.gg INT007452
- MeSH (NLM) D004979EthamsylateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 24YL531VOHETHAMSYLATEConfirmed FDA, NLM, Wikidata
- RxNorm 4112Confirmed FDA, Wikidata
- Wikidata Q2000876ethamsylateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C171814EthamsylateOne source FDA
- DrugBank DB13483One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D004979 | Ethamsylate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 24YL531VOH | ETHAMSYLATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 4112 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2000876 | ethamsylate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C171814 | Ethamsylate | One source FDA |
| DrugBank | DB13483 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.